Zobrazeno 1 - 10
of 2 261
pro vyhledávání: '"Major adverse cardiac events"'
Publikováno v:
Texas Heart Institute Journal, Vol 51, Iss 2, Pp 1-12 (2024)
Background: A score based on age, creatinine level, and ejection fraction as well as hematocrit value and the presence of emergency surgery (ACEF-II) has been proposed to have predictive value for risk stratification in cardiac surgery. This study ai
Externí odkaz:
https://doaj.org/article/0a0eb12f73bf496ca8a8ba9873857116
Autor:
Alexander Isaak, Johannes Wirtz, Dmitrij Kravchenko, Narine Mesropyan, Leon M. Bischoff, Simon Bienert, Leonie Weinhold, Claus C. Pieper, Ulrike Attenberger, Can Öztürk, Sebastian Zimmer, Daniel Kuetting, Julian A. Luetkens
Publikováno v:
Insights into Imaging, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Objectives To assess the prognostic value of cardiac MRI (CMR) parameters for the occurrence of major adverse cardiac events (MACE) in patients with infarct-like myocarditis. Methods In this retrospective single-center study, patients with C
Externí odkaz:
https://doaj.org/article/eb37cf9d0cc447b1bb6ffadb38755693
Autor:
Gabriele Ferrari, Richard Loayza, Ava Azari, Håkan Geijer, Yang Cao, Roland Carlsson, Leif Bojö, Ninos Samano, Domingos Souza
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Objectives To evaluate the long-term angiographic patency of saphenous vein grafts (SVG) harvested using the no-touch technique compared to the conventional technique. Methods This was a single-center, retrospective, cohort study. The inclus
Externí odkaz:
https://doaj.org/article/75fa2e51b8c84683ab4d903009b47df8
Publikováno v:
Zhongguo quanke yixue, Vol 28, Iss 03, Pp 372-378 (2025)
Background The dual antiplatelet therapy of aspirin combined with ticagrelor is the preferred antiplatelet therapy for patients with ST segment elevation myocardial infarction (STEMI) who receive primary percutaneous coronary intervention (PPCI). Com
Externí odkaz:
https://doaj.org/article/966b1cb4f52c4a808efc4a38bbf7462e
Autor:
Danielle Scharp, PhD, APRN, Yihong Zhao, PhD, Liesbet Van Bulck, PhD, RN, Alexander Volodarskiy, MD, David Slotwiner, MD, Meghan Reading Turchioe, PhD, MPN, RN
Publikováno v:
Heart Rhythm O2, Vol 5, Iss 10, Pp 741-743 (2024)
Externí odkaz:
https://doaj.org/article/90134ee75ff1493eb97478033bde9696
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background CMD refers to the abnormalities of the tiny arteries and capillaries within the coronary artery system, which result in restricted or abnormal blood flow. CMD is an important mechanism involved in ischemic heart disease and second
Externí odkaz:
https://doaj.org/article/fbd80f2e346042d5954381dbbe078aea
Publikováno v:
Clinical Interventions in Aging, Vol Volume 19, Pp 1597-1606 (2024)
Tianqing Cao,1,* Fei Liu,2,* Yan Yao,2 Danghong Sun,2 Rong Wang,3 Junxia Cao,3 Jie Meng,2 Ling Zhang,4 Weiming Li1 1Shanghai Tenth People’s Hospital, Clinical Medical College of Nanjing Medical University, Nanjing, People’s Republic of Ch
Externí odkaz:
https://doaj.org/article/6fc0885247af4e7e86b7ced4b62a2c89
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 14, Iss 5, Pp 550-557 (2024)
Background: The association between Chinese herbal medicine (CHM) and the risk of developing major adverse cardiovascular events (MACEs) in patients with dialysis hypotension is unclear and has not yet been investigated. This study aimed to determine
Externí odkaz:
https://doaj.org/article/8f4c510f1415432c95c554f6224d9245
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) have demonstrated efficacy in improving mortality and cardiovascular (CV) outcomes. However, the impact of GLP-1RAs therapy on cardiorenal outcomes of diabetic patients at the c
Externí odkaz:
https://doaj.org/article/c13e2393f5194c9db441d7d387d78f58
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background Atherogenic index of plasma (AIP) has been reported as a critical predictor on the risks and clinical outcomes of cardiovascular diseases (CVDs), and we aimed to explore the potential predictive value of cumulative AIP on major ad
Externí odkaz:
https://doaj.org/article/4bea0a374946488cadbc716ed59db9e9